SKINVIVE vs Profhilo: Differences, Cost, Results & Suitability
SKINVIVE by JUVÉDERM and Profhilo are two injectable hyaluronic acid treatments used in aesthetic medicine to address aspects of skin quality. Although both are associated with skin hydration treatments, they differ in formulation, treatment technique, clinical evidence and typical treatment protocols.
SKINVIVE is a cross-linked hyaluronic acid dermal filler with specific US FDA indications for improving cheek skin smoothness and reducing neck lines.
Profhilo contains stabilised hybrid complexes of hyaluronic acid and has been investigated for skin-quality concerns, including hydration, elasticity and the appearance of certain age-related changes.
Both may be discussed under the broader category of skin booster injections, but they are not interchangeable treatments. Neither is primarily intended to replace significant facial volume or provide surgical-type lifting.
This SKINVIVE vs Profhilo comparison examines their differences, benefits, clinical results, treatment sessions, longevity, side effects, suitability and cost in India, helping patients understand which approach may be relevant to their skin concerns.
SKINVIVE vs Profhilo: Key Differences at a Glance
Comparison | SKINVIVE by JUVÉDERM | Profhilo |
Formulation | Cross-linked hyaluronic acid gel containing lidocaine | Stabilised hybrid complexes of high- and low-molecular-weight hyaluronic acid |
Product classification | Hyaluronic acid dermal filler | Injectable hyaluronic acid medical device used for skin-quality applications |
Principal focus | Skin smoothness and specified neck-line outcomes | Hydration, elasticity and other investigated skin-quality measures |
US FDA indications | Cheek skin smoothness and neck-line reduction in adults over 21 | No corresponding US FDA indication established in the evidence reviewed |
Injection approach | Intradermal for cheeks; intradermal and/or subdermal for neck under US labelling | Product-specific technique; facial Bio Aesthetic Point protocol is commonly used |
Common initial schedule | Often one treatment, with possible touch-up | Commonly two sessions approximately four weeks apart |
Structural volume restoration | Not the primary objective | Not the primary objective |
Longevity evidence | Defined cheek and neck outcomes demonstrated through six months | Varies by study, formulation and measured outcome |
Clinic price per session | ₹25,000–₹35,000 | Starting at ₹40,000 |
Illustrative initial-course cost | ₹25,000–₹35,000 if one session is sufficient | Approximately ₹80,000 for a two-session course |
The SKINVIVE regulatory indications above refer to the United States. They do not establish identical product authorisation or treatment indications in India. Profhilo applications must also be assessed against current locally applicable product documentation. Prices reflect The Face Clinic’s published figures and should be confirmed before treatment.
Which Treatment May Be More Relevant to Your Skin Concern?
The decision between SKINVIVE or Profhilo should begin with the concern being treated.
Your primary concern | Approach worth discussing |
Uneven cheek skin smoothness | SKINVIVE has specific clinical evidence supporting this outcome |
Dehydration with reduced elasticity | Profhilo may be considered following individual assessment |
Fine surface lines | The underlying cause and treatment area determine suitability |
Horizontal neck lines | SKINVIVE has a specific US indication; Indian use requires separate product and regulatory verification |
Hollow or flattened cheeks | Structural dermal filler assessment may be more relevant |
Significant facial sagging | Neither treatment is a substitute for structural lifting |
Pigmentation or melasma | Neither is primarily a pigmentation treatment |
These are clinical considerations, not fixed prescribing rules.
A patient may have several concerns simultaneously. The appropriate treatment depends on individual anatomy, medical history, expected benefits and the evidence supporting the intended result.
The essential question is not which product is more popular, but which treatment is suitable for the specific concern being addressed.
What Is the Difference Between SKINVIVE and Profhilo?
The fundamental difference between SKINVIVE and Profhilo lies in their hyaluronic acid technology, physical properties, administration techniques and supporting clinical evidence.
Although both contain hyaluronic acid, the presence of a common ingredient does not make their formulations or treatment objectives equivalent.
SKINVIVE — Cross-Linked Hyaluronic Acid for Skin Smoothness
SKINVIVE by JUVÉDERM is a cross-linked hyaluronic acid injectable gel containing lidocaine.
Cross-linking modifies the physical characteristics of the hyaluronic acid gel and influences how it behaves within tissue.
SKINVIVE belongs to the dermal filler category. However, its specified skin-quality applications differ from the principal purpose of conventional volumising fillers, which may be used to restore facial fullness, create projection or refine facial contours.
For its original US cheek indication, SKINVIVE is administered intradermally to improve skin smoothness.
It would therefore be inaccurate to describe SKINVIVE as categorically not a filler or to claim that it produces absolutely no local tissue-volume effect.
Its primary treatment objective differs from structural facial augmentation.
International patients may also encounter the name JUVÉDERM VOLITE. The original FDA documentation identifies VOLITE as a name used outside the United States; the precise formulation and applicable product instructions should be checked for the relevant market.
For treatment-specific details, see SKINVIVE treatment in Delhi.
Profhilo — Hybrid Hyaluronic Acid Complexes
Profhilo contains stabilised hybrid cooperative complexes of high- and low-molecular-weight hyaluronic acid, produced using IBSA’s NAHYCO technology.
Unlike conventionally chemically cross-linked hyaluronic acid fillers, its hybrid complexes are manufactured through a thermal process without chemical cross-linking agents.
The standard Profhilo facial formulation investigated in published studies contains 64 mg of hyaluronic acid in 2 mL, comprising 32 mg each of high- and low-molecular-weight hyaluronic acid.
Profhilo is frequently described as a skin bioremodelling treatment.
This term relates to proposed and investigated effects on skin-quality characteristics. It should not be interpreted as proof of significant facial lifting, permanent regeneration or structural augmentation.
Published studies have evaluated hydration, elasticity, skin density, transepidermal water loss and wrinkle-related measures, with findings varying by study.
For clinical and treatment information, see Profhilo treatment in Delhi.
H3: How Are SKINVIVE and Profhilo Injected?
The two treatments use different product-specific injection protocols.
Under its US labelling, SKINVIVE is administered intradermally for cheek skin smoothness. Its expanded neck indication permits intradermal and/or subdermal placement.
Profhilo facial treatment commonly uses the Bio Aesthetic Point (BAP) technique, involving selected anatomical injection points.
A published study involving Chinese women used five points on each side of the face, with two treatment sessions four weeks apart.
However, this does not establish a universal injection pattern for every patient, anatomical area or formulation.
The number of injection points alone does not determine which procedure is safer, more effective or more comfortable.
Treatment technique must be considered alongside facial anatomy, product instructions, the intended outcome and practitioner experience.
SKINVIVE vs Profhilo Benefits: Which Skin Concerns Can They Address?
Patients often describe their concerns using expressions such as dehydrated skin, dullness, early ageing, reduced firmness or tired-looking skin.
These descriptions can represent different underlying changes.
Skin hydration, surface texture, elasticity, facial volume and tissue laxity are related but distinct characteristics of facial ageing.
SKINVIVE Benefits — Skin Smoothness and Selected Skin-Quality Outcomes
SKINVIVE’s original US FDA indication is supported by clinical evidence demonstrating improvement in cheek skin smoothness.
Separate research has also evaluated hydration and certain skin-texture outcomes associated with VYC-12 formulations.
In June 2026, SKINVIVE received an additional US FDA indication for reducing neck lines to improve neck appearance.
These findings support defined clinical outcomes. They should not be interpreted as establishing equivalent effectiveness for every type of wrinkle, pigmentation concern, facial laxity or anatomical area.
SKINVIVE is not primarily intended to restore substantial cheek volume or replace structural facial contouring.
For a detailed explanation of how this category differs from volumising fillers, read What Is SKINVIVE? How It Differs From Traditional Dermal Fillers.
Profhilo Benefits — Hydration, Elasticity and Skin Quality
Profhilo has been studied for several skin-quality outcomes, including hydration, elasticity-related parameters, skin density and wrinkle severity.
Some studies have reported improvements or trends towards improvement in selected measures.
However, these findings depend on the study population, anatomical area, measurement technique, product formulation and follow-up duration.
Profhilo should not be described as a guaranteed skin-tightening or facial-lifting procedure.
Although certain studies have evaluated changes in laxity or facial-volume-loss scores, an improvement on a clinical scale does not necessarily demonstrate structural volume restoration.
Skin Quality Is Not the Same as Facial Volume
A patient may have relatively smooth skin but reduced facial volume, or adequate volume alongside dehydration and changes in texture.
These concerns do not always respond to the same treatment.
Improving superficial skin smoothness does not necessarily restore cheek projection.
Similarly, improvements in measured elasticity do not automatically establish lifting of descended facial tissues.
When structural volume loss is the main concern, assessment for dermal fillers in Delhi may be more relevant.
Patients primarily concerned about texture, hydration or other skin-quality changes may instead benefit from discussing the different categories of skin booster treatments.
The appropriate starting point is identifying the underlying concern rather than selecting a product based on its promotional description.
SKINVIVE vs Profhilo Sessions, Procedure and Recovery
Treatment scheduling is an important practical difference between these injectable skin hydration treatments.
However, the number of appointments does not independently establish which product is more effective or longer-lasting.
How Many SKINVIVE Sessions Are Usually Required?
SKINVIVE may involve one initial session, with an additional touch-up considered according to the applicable protocol and individual response.
In the original US cheek-smoothness clinical study, an optional touch-up was permitted approximately one month after the initial treatment.
Further treatment depends on the anatomical area, clinical objective, product quantity and individual response.
One session should not be interpreted as a guarantee of a specific outcome.
How Many Profhilo Sessions Are Usually Required?
A commonly used facial Profhilo protocol involves two treatment sessions approximately four weeks apart.
This schedule has also been used in published clinical research.
However, treatment requirements may differ according to the product formulation, treatment area, skin condition and individual response.
A two-session starting protocol does not guarantee that no additional treatment will ever be required.
What Happens Before, During and After Treatment?
Treatment stage | SKINVIVE | Profhilo |
Before treatment | Medical assessment and treatment-area planning | Medical assessment and treatment-area planning |
During treatment | Multiple injections according to the relevant product protocol | Injections at selected anatomical points according to the relevant protocol |
Initial course | Often one session; touch-up if indicated | Commonly two sessions |
Immediately afterwards | Temporary redness, swelling, tenderness, bruising or bumps may occur | Similar injection-site reactions and temporarily raised areas may occur |
Follow-up | Based on response and product guidance | Based on response and completion of the prescribed course |
Patients should disclose relevant medical conditions, medications, previous injectable treatments and allergies during consultation.
Prescribed medications, including anticoagulants, should not be discontinued without guidance from the relevant prescribing clinician.
When Can You Expect to Notice Results?
The timing of visible improvement differs between individuals and protocols.
SKINVIVE: The original pivotal cheek study evaluated its primary endpoint one month after initial treatment or optional touch-up. Some patients may notice changes earlier, but the trial does not establish an identical onset for everyone.
Profhilo: The commonly used initial facial protocol involves two sessions approximately four weeks apart. Published studies have assessed outcomes over subsequent weeks, including follow-up through Week 12.
Early swelling can temporarily influence appearance following either treatment.
Patients should distinguish immediate post-injection changes from outcomes assessed at appropriate clinical follow-up.
How Much Downtime Should You Expect?
Both procedures involve injections and may produce visible injection-site reactions.
SKINVIVE can cause temporary bumps, firmness, swelling or bruising.
Profhilo may produce raised areas at selected injection points that gradually settle.
The severity and duration of these reactions vary.
Neither treatment should be described as having absolutely no downtime.
Patients preparing for weddings, professional events or other important occasions should discuss treatment scheduling and recovery expectations during consultation.
SKINVIVE vs Profhilo Results: What Does Clinical Evidence Show?
Both treatments have published clinical evidence, but their studies do not consistently evaluate identical outcomes.
SKINVIVE’s US FDA pivotal studies examine specified clinical endpoints, while Profhilo research includes multiple skin-quality measures across studies with different designs.
Directly comparing percentages from unrelated studies can therefore be misleading.
SKINVIVE Clinical Results — Cheek Skin Smoothness
SKINVIVE received its original US FDA approval for improving cheek skin smoothness in adults over 21 on May 11, 2023.
The pivotal study involved 209 randomised participants and compared SKINVIVE treatment with an untreated control group.
The findings included:
- 57.9% of SKINVIVE-treated participants achieved the predefined cheek-smoothness response at one month after initial treatment or optional touch-up.
- 4.5% of untreated controls achieved the same response threshold.
- 55.6% of treated participants with evaluable six-month data continued to meet the defined response threshold.
The primary assessment used the Allergan Cheek Smoothness Scale, with response defined as an improvement of at least one grade.
The one-month analysis used imputed data, whereas the six-month figure was based on observed data from evaluable treated participants.
These results provide evidence for a specific cheek-smoothness outcome.
They do not imply that 57.9% of patients experienced every possible skin-quality benefit or that everyone maintained an identical result for six months.
Clinical reference: US FDA — Original SKINVIVE Summary of Safety and Effectiveness Data.
SKINVIVE Neck-Line Results — June 2026 FDA Approval
On June 11, 2026, the US FDA expanded SKINVIVE’s indications to include reducing neck lines for improvement of neck appearance in adults over 21.
This was a separate regulatory decision supported by a separate clinical investigation.
The neck study reported:
- 74.8% of SKINVIVE-treated participants achieved the predefined neck-line response threshold at the primary assessment.
- 16.1% of untreated controls achieved that threshold.
- 66.0% of treated participants with evaluable six-month data maintained the defined improvement.
The primary endpoint involved an improvement of at least one grade on the Allergan Transverse Neck Lines Scale.
The study therefore supports a defined neck-line indication rather than a general claim that SKINVIVE lifts sagging neck tissues.
Regulatory reference: US FDA — SKINVIVE June 2026 approval record.
These are US regulatory findings. The products, treatment indications and instructions applicable in India must be verified separately.
Profhilo Clinical Results — What Has Been Demonstrated?
Profhilo has been investigated for outcomes including hydration, elasticity-related measures, skin density and wrinkle appearance.
The research suggests potential benefits in selected aspects of skin quality, although the certainty of evidence varies.
Evidence from a 2026 systematic review
A systematic review published in 2026 examined nine studies involving 278 participants treated with Profhilo or Profhilo Body.
The authors reported statistically significant changes or trends towards improvement in several parameters, including hydration, elasticity-related measures, skin density, laxity and selected wrinkle-related scores.
However, the included studies differed in:
- Treatment area and product formulation.
- Study population and sample size.
- Clinical measurement techniques.
- Follow-up duration.
- Methodological design and risk of bias.
Findings involving Profhilo Body should not automatically be generalised to standard facial Profhilo treatment.
Three authors of the review were affiliated with IBSA, the product manufacturer. This potential conflict of interest is relevant when evaluating the findings.
The review is useful for understanding the available research but does not establish that Profhilo is superior to SKINVIVE.
Research reference: A Systematic Review of the Efficacy and Safety of Profhilo and Profhilo Body — PubMed.
Evidence from an Asian facial study
A prospective, open-label study involving 30 Chinese women investigated Profhilo administered in two facial sessions four weeks apart.
Participants were followed through Week 12.
Researchers reported statistically significant improvements in superficial skin hydration and transepidermal water loss at Week 12 compared with baseline.
However, hydration measurements at that assessment were available for only six participants.
Some wrinkle-severity and facial-volume-loss measurements showed changes, but findings across individual time points were not consistently statistically significant. Certain elasticity-related findings were also less conclusive.
Because the study was small and lacked a control group, it cannot establish comparative superiority over SKINVIVE.
Research reference: Profhilo in Asian Patients — Aesthetic Plastic Surgery.
Is SKINVIVE More Effective Than Profhilo?
There is insufficient robust, directly comparable clinical evidence to establish that either treatment is universally superior.
SKINVIVE’s cheek-smoothness response rate cannot be directly compared with Profhilo hydration measurements obtained using different endpoints, populations and methodologies.
Similarly, an FDA-approved indication for SKINVIVE does not automatically mean it is better for every concern involving skin quality.
The clinically meaningful question is which product has appropriate evidence for the outcome the patient wants to address.
How Long Does SKINVIVE vs Profhilo Last?
When comparing SKINVIVE vs Profhilo longevity, three concepts should be distinguished:
- The duration of a result measured in a clinical study.
- How long a patient personally perceives a benefit.
- The interval at which further treatment may be considered.
These are related but not identical.
How Long Does SKINVIVE Last?
The original SKINVIVE cheek-smoothness study reported that 55.6% of treated participants with evaluable six-month data continued to meet the defined response threshold.
This provides a six-month clinical reference for that particular outcome.
The separate neck-line study also reported six-month findings, but involved a different anatomical area and clinical endpoint.
Neither result guarantees that every patient experiences equivalent improvement for six months.
Other research involving related VYC-12 formulations has examined hydration-related outcomes over different periods, but those findings should not be presented as universal SKINVIVE longevity guarantees.
How Long Does Profhilo Last?
Profhilo’s reported duration varies according to the formulation, clinical outcome, treatment schedule and study follow-up.
The cited Asian facial study assessed outcomes through Week 12.
Other research has used different follow-up intervals.
Maintenance may be considered according to individual response, but a recommended maintenance interval does not prove that every benefit lasts for exactly that period.
Claims of universal nine- or twelve-month results therefore require appropriately matched evidence.
Which Treatment Lasts Longer?
Available studies do not establish that SKINVIVE or Profhilo invariably lasts longer.
A fair comparison requires the same clinical outcome, similar anatomical areas, comparable patient populations and appropriate follow-up periods.
Until directly comparable evidence is available, it is more accurate to discuss the supported duration of individual outcomes than to rank the products by overall longevity.
SKINVIVE vs Profhilo Cost in India
When comparing SKINVIVE vs Profhilo cost, the total initial treatment course is more informative than the price of an individual session.
The final cost depends on the product, quantity required, anatomical area, number of sessions and whether additional treatment is clinically indicated.
At The Face Clinic in Hauz Khas, South Delhi, the published prices are:
Cost consideration | SKINVIVE | Profhilo |
Price per session | ₹25,000–₹35,000 | Starting at ₹40,000 |
Common starting course | One session may be sufficient | Usually two sessions approximately four weeks apart |
Illustrative initial-course cost | ₹25,000–₹35,000 | Approximately ₹80,000 |
Additional treatment | Published top-up starting at ₹15,000, where indicated | Determined by the individual treatment plan |
Maintenance | Individualised | Individualised |
These figures are clinic-specific prices, not nationwide average prices. Treatment requirements and final quotations must be confirmed during consultation.
Why Is the Complete Treatment Cost More Relevant?
A patient may interpret a lower single-session price as meaning that one treatment is less expensive overall.
However, initial protocols can involve different numbers of appointments.
For example, one clinically appropriate SKINVIVE session may involve a lower initial expenditure than a two-session Profhilo course.
This does not demonstrate superior value or clinical effectiveness.
The two protocols may differ in product quantity, treatment area, intended outcome and the possible need for additional sessions.
Patients should understand the entire recommended treatment plan before comparing costs.
For current service information, see SKINVIVE treatment and cost in Delhi and Profhilo treatment and pricing in Delhi.
SKINVIVE vs Profhilo Safety, Side Effects and Contraindications
Both SKINVIVE and Profhilo involve injections and carry potential risks.
Safety must be considered in relation to the product formulation, injection technique, treatment area, medical history and individual patient factors.
Neither treatment is universally risk-free or appropriate for everyone.
What Are the Common Side Effects?
Temporary injection-site reactions may include:
- Redness or tenderness.
- Swelling or bruising.
- Localised bumps or raised areas.
- Firmness or discomfort.
- Itching or temporary discolouration.
SKINVIVE’s product information includes injection-site reactions such as redness, bruising, swelling, lumps or bumps and tenderness.
Profhilo may also cause visible elevations at selected injection points shortly after treatment.
The severity and duration of these reactions vary between individuals.
Persistent, worsening or unusual reactions should be medically assessed.
Are Serious Complications Possible?
Although many reactions are temporary, injectable hyaluronic acid procedures can also be associated with less common complications such as infection, inflammatory responses, nodules and hypersensitivity.
Unintentional intravascular injection of filler material can cause serious harm.
The US FDA warns that vascular complications involving dermal fillers may include tissue injury, visual impairment and, rarely, stroke.
These general warnings do not establish that SKINVIVE and Profhilo have identical rates of serious complications. Reliable comparative evidence would be necessary to quantify any differences.
Warning signs requiring urgent assessment include unusual severe pain, skin blanching or discolouration, sudden visual changes or neurological symptoms during or after treatment. Visual or neurological symptoms require emergency medical care.
For further information, see the US FDA guidance on dermal filler risks and precautions.
Who May Not Be Suitable for SKINVIVE or Profhilo?
Medical assessment should consider:
- Known allergies or previous severe allergic reactions.
- Active infection or inflammation at the proposed injection site.
- Relevant medical conditions and prescribed medications.
- Previous injectable treatments and complications.
- Pregnancy or breastfeeding, where safety information may be insufficient.
- Product-specific contraindications and precautions.
SKINVIVE’s original US product information includes contraindications relating to severe allergies, certain bacterial-protein sensitivities and lidocaine allergy.
Profhilo has its own product-specific instructions and contraindications.
Precautions for one product should not automatically be assumed to apply identically to the other.
Suitability requires individual clinical assessment, discussion of expected benefits and risks, and informed consent.
Can SKINVIVE and Profhilo Be Combined?
SKINVIVE and Profhilo have overlapping skin-quality applications, but this does not automatically justify combining them.
Some patients may have several concerns simultaneously, including uneven smoothness, reduced hydration and changes in elasticity.
However, multiple concerns do not necessarily require multiple injectable products.
Before considering combination treatment, the doctor should assess:
- Whether each product has a distinct clinical objective.
- Whether the proposed anatomical areas and timing are appropriate.
- Whether the expected additional benefit justifies more injections and cost.
- Whether previous treatment response or complications affect suitability.
Robust evidence establishing that routine combination treatment provides superior outcomes to appropriately selected single-product treatment has not been demonstrated in the evidence considered here.
Combining treatments should therefore not be presented as a standard upgrade or a guaranteed way to achieve better results.
SKINVIVE or Profhilo — How Is the Right Treatment Selected?
Choosing between SKINVIVE or Profhilo begins with examining the skin and identifying the underlying concern.
A patient describing tired-looking skin may have reduced hydration, changes in texture, loss of elasticity, facial-volume deficiency or a combination of these findings.
These concerns require different clinical considerations.
Why Facial Assessment Matters More Than Product Popularity
At The Face Clinic, treatment planning involves assessment of skin quality, facial anatomy, medical history, previous procedures and individual goals.
The doctor also considers the clinical evidence, product-specific risks, possible downtime and financial commitment.
For example, a patient with superficial texture changes and significant midface volume loss may need the two concerns evaluated separately.
Improving the surface appearance of the skin does not necessarily correct underlying structural volume loss.
Similarly, improving skin elasticity does not automatically produce meaningful lifting of descended tissues.
The objective is to determine whether SKINVIVE, Profhilo, another treatment category or no injectable intervention is appropriate.
Dr Reema Arora’s Approach to Skin-Quality Assessment
Dr Reema Arora, Founder and Medical Director of The Face Clinic, has over 20 years of experience in facial aesthetics and has trained medical professionals in injectable treatment techniques.
Her clinical approach emphasises assessment of facial anatomy, tissue characteristics and treatment objectives before deciding on an injectable procedure.
A successful treatment plan begins by distinguishing changes involving skin quality from those involving deeper facial structure.
This distinction helps prevent a skin-quality product from being selected for a concern that primarily requires a different treatment strategy.
Is SKINVIVE or Profhilo Better for Indian Skin?
Indian patients represent a wide range of skin tones, tissue characteristics and aesthetic concerns.
Skin colour or ethnicity alone does not establish suitability for either treatment.
Individual factors include medical history, previous procedures, pigmentation tendencies, skin condition and facial anatomy.
Profhilo has been investigated in Asian patients, including the cited study involving Chinese women. However, findings from a small population should not automatically be generalised to all Indian patients.
Similarly, SKINVIVE’s clinical evidence does not establish that everyone with a particular skin type will experience identical results.
Patients prone to post-inflammatory pigmentation or persistent skin reactions should discuss that history during consultation.
The appropriate decision should reflect individual clinical findings rather than an assumption that either treatment is universally better for Indian skin.
Frequently Asked Questions About SKINVIVE vs Profhilo
1. What Is the Main Difference Between SKINVIVE and Profhilo?
SKINVIVE is a cross-linked hyaluronic acid dermal filler with US FDA indications for cheek skin smoothness and neck-line reduction. Profhilo contains stabilised hybrid hyaluronic acid complexes and has been studied for hydration, elasticity and other skin-quality outcomes.
Their formulations, treatment protocols and supporting evidence differ.
2. Is SKINVIVE or Profhilo Better for Skin Hydration?
Both have skin-quality applications involving hydration-related concerns. However, their studies use different methods and endpoints, so current evidence does not establish that either provides universally superior hydration results.
3. Is Profhilo Better for Sagging Skin?
Profhilo has been investigated for selected elasticity- and laxity-related measures. However, improved skin quality does not necessarily mean meaningful lifting of descended facial tissues.
Significant sagging requires assessment of the underlying anatomical cause.
4. Is SKINVIVE a Dermal Filler or a Skin Booster?
SKINVIVE is classified as a hyaluronic acid dermal filler.
It is commonly described as a skin booster because its intended clinical applications focus on selected skin-quality outcomes rather than conventional structural volume augmentation.
5. What Should Patients Look for in SKINVIVE vs Profhilo Reviews?
Patient reviews may describe individual experiences, but they cannot establish clinical superiority.
Consider the treatment area, number of sessions, baseline skin condition and timing of assessment.
Before-and-after photographs should also be evaluated with attention to lighting, facial expression, camera positioning and treatment timing.
6. Which Treatment Lasts Longer — SKINVIVE or Profhilo?
SKINVIVE has clinical evidence demonstrating specified cheek-smoothness outcomes through six months in a proportion of treated participants.
Profhilo research evaluates different outcomes over varying follow-up periods.
The available studies do not establish that either treatment consistently lasts longer for everyone.
7. Can SKINVIVE and Profhilo Be Used on the Neck?
SKINVIVE received a separate US FDA indication in June 2026 for reducing neck lines in adults over 21.
Profhilo and related formulations have also been investigated for neck skin-quality applications.
Product-specific instructions, local regulatory requirements, anatomy and individual suitability must guide treatment decisions.
8. What Is the SKINVIVE vs Profhilo Cost in India?
At The Face Clinic, SKINVIVE is published at approximately ₹25,000–₹35,000 per session, while Profhilo starts at ₹40,000 per session.
A typical two-session Profhilo facial course would therefore cost approximately ₹80,000 at the stated starting price.
Final cost depends on the proposed treatment plan.
9. Do These Treatments Replace Conventional Facial Fillers?
Neither is primarily intended for structural facial augmentation.
SKINVIVE belongs to the filler category but has specific skin-quality applications, while Profhilo is generally used for selected skin-quality concerns.
Patients with significant facial-volume loss may require a different assessment.
10. Can SKINVIVE Be Performed After Profhilo?
Previous Profhilo treatment does not automatically prevent or justify subsequent SKINVIVE treatment.
Timing, treatment area, previous response and potential complications should be reviewed before recommending another injectable.
There is no universally appropriate sequence for every patient.
11. How Far Before an Important Event Should Treatment Be Planned?
Neither treatment should be considered a guaranteed last-minute procedure.
Visible injection-site reactions may occur, and the commonly used Profhilo facial protocol involves two initial sessions approximately four weeks apart.
Treatment scheduling should be discussed with the doctor well before an important event.
12. Are SKINVIVE and Profhilo Suitable for All Skin Types?
Neither treatment is automatically suitable for everyone.
Skin type is only one factor. Medical history, allergies, previous procedures, treatment area and product-specific contraindications also influence suitability.
Individual assessment is necessary before treatment.
SKINVIVE vs Profhilo — Making an Informed Treatment Decision
SKINVIVE and Profhilo are distinct hyaluronic acid injectables with different formulations, treatment protocols and supporting clinical evidence.
SKINVIVE has defined US regulatory evidence for improving cheek skin smoothness and reducing neck lines. Profhilo has been investigated for several aspects of skin quality, including hydration and elasticity, although the strength of evidence varies across outcomes.
Neither should be selected solely because it is popular, newer or widely promoted.
An informed decision requires understanding the underlying concern, expected benefits, evidence limitations, potential risks and treatment commitment.
The most appropriate treatment is not necessarily the one promising the greatest number of benefits, but the one supported by a sound clinical rationale for the individual patient.
Discuss Skin-Quality Treatment Options at The Face Clinic
At The Face Clinic in Hauz Khas, South Delhi, Dr Reema Arora, Founder and Medical Director, brings over 20 years of experience in facial aesthetics to individual treatment assessment.
Consultations consider skin condition, facial anatomy, medical history, previous treatments and personal goals before discussing suitable options.
The objective is not to recommend SKINVIVE or Profhilo automatically, but to determine whether either has an appropriate role in the patient’s overall treatment plan.
The Face Clinic — Dr Reema Arora
C-36, Lower Ground Floor, Chaudhary Dilip Singh Marg, Hauz Khas Market, New Delhi – 110016, India.
Clinic hours: Monday–Saturday, 10:00 AM–6:00 PM
Telephone: +91 99580 73900
Book a consultation | WhatsApp The Face Clinic
Treatment recommendations are subject to individual clinical assessment. Results and potential risks vary. This article is intended for educational purposes and does not replace personalised medical advice.
